Rvnc deadline tomorrow: rosen, national investor counsel, encourages revance therapeutics, inc. investors to secure counsel before important march 4 deadline in securities class action – rvnc

San jose, calif., march 03, 2025 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of revance therapeutics, inc. (nasdaq: rvnc) between february 29, 2024 and december 6, 2024, both dates inclusive (the “class period”), of the important march 4, 2025 lead plaintiff deadline.
RVNC Ratings Summary
RVNC Quant Ranking